Kathmandu, June 4: Permission has been granted for use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.
The Department of Drug Administration (DDA) granted the approval for the use of the vaccine today.
The DDA has already given permission for the use of Sinopharm COVID-19 vaccine (commonly understood as Vero Cell in Nepal), another Chinese COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
China has provided 1.8 million doses of Sinopharm COVID-19 vaccine as grant assistance to Nepal.
World Health Organisation (WHO) has listed both the COVID-19 vaccines for emergency use, giving the green light for these vaccines to be rolled out globally.
– TRN Online